- Home
- TNXP vs AFRI Comparison
TNXP vs AFRI Comparison
Compare TNXP & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNXP | AFRI |
|---|---|---|
| Founded | 2007 | 1943 |
| Country | United States | Gibraltar |
| Employees | 81 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.5M | 235.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TNXP | AFRI |
|---|---|---|
| Price | $17.08 | $10.34 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $70.00 | N/A |
| AVG Volume (30 Days) | ★ 455.8K | 20.6K |
| Earning Date | 03-17-2026 | 12-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,299,000.00 | ★ $201,916,000.00 |
| Revenue This Year | $7.00 | N/A |
| Revenue Next Year | $718.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.76 | $7.47 |
| 52 Week High | $69.97 | $11.42 |
Technical Indicators
Market Signals| Indicator | TNXP | AFRI |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 41.19 |
| Support Level | $17.17 | $9.90 |
| Resistance Level | $18.75 | $10.24 |
| Average True Range (ATR) | 1.20 | 0.43 |
| MACD | 0.15 | -0.05 |
| Stochastic Oscillator | 43.98 | 45.80 |
Price Performance
Historical ComparisonAbout TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.